PMS33 COST EFFECTIVENESS OF ABATACEPT IN COMPARISON WITH OTHER BIOLOGIC THERAPIES FOR THE TREATMENT OF MODERATE TO SEVERE ACTIVE RHEUMATOID ARTHRITIS PATIENTS WHO HAVE FAILED TO METHOTREXATE BASED TREATMENT AT ESSALUD IN 2010
May 1, 2011, 00:00
10.1016/j.jval.2011.02.718
https://www.valueinhealthjournal.com/article/S1098-3015(11)00857-6/fulltext
Title :
PMS33 COST EFFECTIVENESS OF ABATACEPT IN COMPARISON WITH OTHER BIOLOGIC THERAPIES FOR THE TREATMENT OF MODERATE TO SEVERE ACTIVE RHEUMATOID ARTHRITIS PATIENTS WHO HAVE FAILED TO METHOTREXATE BASED TREATMENT AT ESSALUD IN 2010
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)00857-6&doi=10.1016/j.jval.2011.02.718
First page :
A129
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
178